TY  - GEN
AU  - Press,Oliver W
AU  - Unger,Joseph M
AU  - Rimsza,Lisa M
AU  - Friedberg,Jonathan W
AU  - LeBlanc,Michael
AU  - Czuczman,Myron S
AU  - Kaminski,Mark
AU  - Braziel,Rita M
AU  - Spier,Catherine
AU  - Gopal,Ajay K
AU  - Maloney,David G
AU  - Cheson,Bruce D
AU  - Dakhil,Shaker R
AU  - Miller,Thomas P
AU  - Fisher,Richard I
TI  - Phase III randomized intergroup trial of CHOP plus rituximab compared with CHOP chemotherapy plus (131)iodine-tositumomab for previously untreated follicular non-Hodgkin lymphoma: SWOG S0016
SN  - 1527-7755
PY  - 2013///0329
KW  - Antibodies, Monoclonal
KW  - administration & dosage
KW  - Antibodies, Monoclonal, Murine-Derived
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - Consolidation Chemotherapy
KW  - Cyclophosphamide
KW  - Disease-Free Survival
KW  - Doxorubicin
KW  - Humans
KW  - Kaplan-Meier Estimate
KW  - Lymphoma, Follicular
KW  - drug therapy
KW  - Neoplasm Staging
KW  - Prednisone
KW  - Proportional Hazards Models
KW  - Radioimmunotherapy
KW  - methods
KW  - Rituximab
KW  - Vincristine
N1  - Publication Type: Clinical Trial, Phase III; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1200/JCO.2012.42.4101
ER  -